Monitor for potential stock price pressure due to the ATM offering and recent equity sales. The company's low market cap and dilutive financing suggest continued cash burn, which could lead to further dilution if additional capital is needed.
Price Chart
Executive Summary
Hoth Therapeutics is conducting an at-the-market offering of up to $1.555 million in common stock through H.C. Wainwright & Co. The company will pay a 3.0% commission on gross sales. Proceeds will be used for general corporate purposes, capital expenditures, working capital, and administrative expenses. This follows a prior shelf registration and recent equity sales.
Key Facts
- Offering up to $1,555,000 in common stock through an at-the-market (ATM) offering
- H.C. Wainwright & Co. will act as sales agent with a 3.0% commission on gross sales
- Proceeds will be used for general corporate purposes, capital expenditures, working capital, and administrative expenses
- Recent equity sales include $2.45 million on April 2, 2026 and $706,484 in Q1 2026
- Market cap is $11 million with stock trading at $0.51 per share
Financial Impact
Up to $1,555,000 in common stock to be sold, with 3.0% commission paid to the sales agent
Risk Factors
- Dilution to existing shareholders from the new stock issuance
- Potential downward pressure on stock price from continuous sales in the ATM offering
- Risk of not maintaining Nasdaq listing due to low market cap and potential financial instability
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 424B5 Filing (Primary) | 0001213900-26-044740 |
| Document: 0001213900-26-044740-index-headers.html | 0001213900-26-044740 |
| Document: 0001213900-26-044740-index.html | 0001213900-26-044740 |
| Document: 0001213900-26-044740.txt | 0001213900-26-044740 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 23, 2026 4d ago | DEF 14A | — | awaiting T+20 | — | — |
Jun 3, 2026 20w ago | 8-K | $2.14 $0.8880 | ▼ −58.50% | ▼ −57.50% | — |
Jun 3, 2026 20w ago | 8-K | $2.14 $0.8880 | ▲ +58.50% | ▲ +57.50% | — |
Jun 3, 2026 20w ago | 424B5 | $2.14 $0.8880 | ▲ +58.50% | ▲ +57.50% | — |
Jun 2, 2026 21w ago | 8-K | $2.14 $0.8880 | ▼ −58.50% | ▼ −57.50% | — |
May 28, 2026 21w ago | 8-K | $1.70 $0.9508 | ▼ −44.07% | ▼ −41.63% | — |
May 27, 2026 21w ago | 424B5 | $1.70 $0.9508 | ▲ +44.07% | ▲ +41.63% | — |
May 27, 2026 21w ago | 8-K | $1.36 $0.8750 | ▼ −35.66% | ▼ −33.76% | — |
May 4, 2026 25w ago | 8-K | $0.7100 $2.22 | ▼ −212.68% | ▼ −207.72% | — |
Apr 16, 2026 27w ago | 8-K | $0.7300 $0.6660 | ▼ −8.77% | ▼ −14.14% | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers